Tradestie Institutional Equity Comparison Engine

AMS vs HH โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AMS Overall Edge

AMS Captures Institutional Edge (2โ€“1 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to American Shared Hospital Services (AMS) driven by superior Valuation, Growth & Margin while HH counters with relative strength in Momentum & Technical. Fundamentally, AMS trades at 44.6x Forward P/E with -7.4% operating margin (+19.2% YoY revenue) versus HH at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, AMS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against HH sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner AMS
AMS 44.6x vs HH N/M Fwd P/E
Growth & Margin Winner AMS
Op Margin -7.4% vs N/A ยท YoY +19.2% vs N/A
Momentum & Technical Winner HH
1Y -52.2% vs -0.1% ยท 52W Pos 6% vs 45%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
AMS NYSE American
American Shared Hospital Services
Services-Medical Laboratories
$1.07
-0.93% 1D
Market Cap $7.2M
1M Return -16.41%
1Y Return -52.23%
Forward P/E 44.6x
Unified AI Score
33.8 / 100 SELL
Tech 24.0 Fund 38.0 Flow 50.0 Mom 30.0
HH US Equity
HH
Institutional Equity
$24.97
-0.1% 1D
Market Cap N/A
1M Return -0.1%
1Y Return -0.1%
Forward P/E N/M
Unified AI Score
54.7 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AMS -52.23% HH -0.1% Spread: +16.31 pp (HH Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AMS TTM Op. Margin: -7.4% HH TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AMS vs HH. Trailing 12-month operating profitability (AMS -7.4% vs HH N/A) and valuation multiples (AMS 44.6x vs HH N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AMS (7) vs HH (3)
Institutional Metric AMS HH Criterion Row Winner
Market Capitalization Scale $7.2M N/A Larger Scale AMS
Trailing P/E Ratio Valuation 44.6x N/M Lower Multiple AMS
Forward P/E Ratio Valuation 44.6x N/M Lower Multiple AMS
Revenue Growth (YoY) Growth +19.2% N/A Higher Growth AMS
Operating Margin (TTM) Profitability -7.4% N/A Higher Margin AMS
Net Profit Margin Profitability -5.8% N/A Higher Margin AMS
Return on Equity (ROE) Capital Efficiency -12.1% N/A Higher ROE AMS
52-Week Range Position Momentum 6% ($1โ€“$2) 45% ($25โ€“$25) Stronger Trend HH
Beta / 30D Volatility Risk Regime 0.18ฮฒ ยท 46% Vol N/A Lower Realized Risk HH
Unified Institutional Score Composite Signal 33.8 / 100 (SELL) 54.7 / 100 (HOLD) Higher Composite HH

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AMS vs HH Buy Guide
AMS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AMS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
HH UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live HH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AMS nor HH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.